Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 14.742% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a CCOC(=O)N1CCN(Cc2oc(CO)cc(=O)c2O)CC1
b CC(C)(C)NC(=O)NC(=O)CSc1ccc(S(=O)(=O)N2CCOCC2)cn1
c CC(Oc1ccccc1)C(=O)N=Nc1c(O)[nH]c2ccc([N+](=O)[O-])cc12
Answer: a. CCOC(=O)N1CCN(Cc2oc(CO)cc(=O)c2O)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOC(=O)N1CCN(Cc2oc(CO)cc(=O)c2O)CC1
CCOC(=O)N1CCN(Cc2oc(CO)cc(=O)c2O)CC1
ethyl4-[[3-hydroxy-6-(hydroxymethyl)-4-oxopyran-2-yl]methyl]piperazine-1-carboxylate